Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2024 financial calendar:
March 21, 2024: Publication of 2023 financial statements
May 14, 2024: Publication of revenue for 1Q2024
May 23, 2024: Annual General Shareholders Meeting
September 12, 2024: Publication of half year financial statements
November 13, 2024: Publication of revenue for 3Q2024
All financial reports are released before market open CET.
All corporate information, such as the Company’s financial statements and corporate presentations, is available in the Investors section on https://www.innate-pharma.com.
| Press Release in English | 108.94 KB |
| Communiqué de presse en français | 91.34 KB |